Ocean Medicines

The secondments of Giovanna Romano, researcher at the SZN, is continuing with interesting results that will be the subject of joint publications.....for sure!

Chiara Papulino is performing her secondment period to the Foundation Medina, Granada

Valeria Di Dato is performing her secondment at the IMBM, University of Western Cape, Cape Town, Za.

Ocean Medicines mid term review meeting and GA meeting!!! Nice to meet all of you again

Silvia Lino, from Sea4Us, is a seconded researcher (ER) of the Ocean Medicines project.
She is spending 2 months of secondment at the Institute of Protein Biochemistry, CNR in Naples, learning how to isolate novel strains of bacteria from sea sponges producing bioactive compounds. Silvia, you are very welcome here in Naples!!!

Emiliana Tortorella is an another seconded researcher (ERS) from the IBP-CNR in the Ocean Medicines project. She is spending a 2-months period at Sea4Us in Lisbon, Portugal, learning how to work with eukaryotic cells and how to test the toxicity of newly isolated compounds!
Good work and good luck Emiliana!!

Pietro Tedesco is the first seconded researcher (ER) in the Ocean Medicines project.
He is spending a 6-months period at the University of Western Cape, Cape Town, South Africa in the Porf. Marla Trinidad' laboratory.

Ocean Medicines is a network of academic, research centres and SMEs across Europe, with proven experience in higher education, training and endowed with state-of-the art scientific and technical expertise and infrastructures.

Our aim is to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium. To achieve this goal a mobility programme will be set up to prepare a new generation of marine biodiscovery scientists that will be trained on how to isolate compounds from bioactive bacteria/microalgae and take these through to semi-industrial scale-up for further development and toxicity testing at the pre-clinical level. The Ocean Medicines programme also considers commercialization, innovation and entrepreneurship activities including how to start a new business and how to favour an industrial career to seconded researchers. We are confident that the establishment of this international research network, with its synergistic effects, will significantly contribute to advance all of the involved labs to the top level in the field of marine drug discovery.

L’obiettivo del progetto è di creare una rete di collaborazioni e di scambi di conoscenze tra i partner industriali e accademici per sviluppare i composti da microrganismi marini che hanno effetti antitumorali ed anti-infettivi. Per raggiungere questo obiettivo sarà istituito un programma di mobilità per preparare una nuova generazione di scienziati che saranno formati su come isolare i composti bioattivi da batteri e microalghe e portare questi fino allo scale-up semi-industriale e valutarne la tossicità a livello pre-clinico.